Table 1.
Means and standard deviations describing calves and data associated with colostrum intake and assessments stratified by treatment group from a randomized clinical trial evaluating the effects of oligosaccharide supplementation on serum IgG concentration and apparent efficiency of IgG absorption in neonatal dairy calves
| Treatment Group | Birth Weight (kg) Mean (SD) | B‐C Time (hours) Mean (SD) | C‐V Time (hours) Mean (SD) | Serum IgG (mg/mL) Mean (SD) | AEA% Mean (SD) | N |
|---|---|---|---|---|---|---|
| MOS | 36.0 (6.0) | 1.55 (0.67) | 27.02 (4.28) | 23.92 (8.26) | 29.6 (8.7) | 33 |
| SGOS | 35.3 (3.8) | 1.30 (0.63) | 25.98 (2.78) | 24.61 (8.57) | 29.5 (9.8) | 31 |
| BGOS | 35.8 (6.5) | 1.37 (0.52) | 27.65 (3.63) | 23.36 (9.85) | 25.4 (8.6) | 28 |
| CON | 35.8 (5.5) | 1.27 (0.69) | 26.48 (2.37) | 25.69 (10.60) | 29.9 (10.3) | 31 |
| All calves | 35.7 (5.4) | 1.38 (0.64) | 26.77 (3.37) | 24.41 (9.26) | 28.7 (9.4) | 123 |
| P | .41 | .3 | .17 | .69 | .26 |
B‐C time = time between birth and colostrum administration; C‐V time = time between colostrum administration and venipuncture for serum IgG concentration; AEA% = apparent efficiency of absorption of IgG; MOS = mannan‐oligosaccharides, SGOS = Saccharomyces galacto‐oligosaccharides; BGOS = Bifidobacterium galacto‐oligosaccharides, and CON = lactose control, P = P‐value for statistical significance for differences among treatment groups.